Seed VC · USA

Venbio Partners

Active

What they invest in

We are a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs.

Who they back

DeepTechHealthtechBiotechSeries ASeries B+

Business models

biotech_therapeutics

Customer segments

Researchers, Pharmaceutical companies

Geography

US

Recent investments

  • Candid Therapeutics
  • Vicebio
  • Pharvaris

The people who write checks

5 partners on file at Venbio Partners, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Venbio Partners writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Venbio Partners alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Sep 2024
Website
www.venbio.com ↗

Other firms investing in DeepTech

See all investors

Is Venbio Partners the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Venbio Partners is one of them, and we'll tell you exactly where they sit in your top 100.